Dear Sir,


With reference to the above matter, we are pleased to invite investors in our company.

Our major strength is through our product, which is an award-winning intranasal vaccine against Pneumonia Pasteurellosis for sheep and goats (small ruminants). It is the World’s first Intranasal Spray-based Anti-Pneumonia Vaccine for Sheep & Goats.

The potential market for the vaccine is huge, as evidenced by:

i Huge population of sheep and goats of 1.8 Billion heads
ii An average 5% – 10% annual growth rate in headcounts
iii Low product presence in Asia and Developing countries
iv Limited number of competitors
v Ineffectiveness of current vaccines and;
vi Relatively Low Cost of Protection against Mortality Value of Animals

As such, we have identified the novel competitive edge of the vaccine as follows:

i Proven effectiveness in reducing mortality rate to 10%, and
ii Novel Intranasal method

Please do not hesitate to contact us for any further details or discussions, and we hope for a positive response from your kind self.


Mon, 2007/09/03 - 20:25

Assalam aleykoum,

I would like to have more information about this project:

at what stage is it today?
How much can I invest?
Where are you based?


Tue, 2008/08/26 - 13:52

I would like to know more about this.

How much it needs to invest?
What would be marketing policies?
This project will worked out in which country?

Thanking you